In a strong indication that its x-ray film business is healthy and growing, Fuji Photo Film has embarked on a $300-million expansion of its manufacturing and distribution operations in Greenville, SC. The expansion includes two new manufacturing
In a strong indication that its x-ray film business is healthy and growing, Fuji Photo Film has embarked on a $300-million expansion of its manufacturing and distribution operations in Greenville, SC. The expansion includes two new manufacturing facilitiesone for color photographic film and photographic paper, the other for x-ray film finishingand a major extension to the companys existing distribution center.
The move is expected to have a positive impact on Fuji Medical Systems conventional and digital x-ray imaging businesses, according to the Stamford, CT-based subsidiary of Fuji Photo Film. In addition to streamlining Fuji Medicals ordering and distribution channels, all x-ray film will now be finished, cut, and packaged in the U.S. rather than Japan, which should improve turnaround times and facilitate custom film orders. The addition of x-ray film finishing capabilities also represents a first step toward total domestic production of Fuji x-ray film for the U.S. market, according to the company. The two new factories are expected to be completed early next year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.